| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 |
|---|
| 84.2 | 84.0 | −19.5 | |
Expenses | |||
| 3,287 | 3,575 | 3,341 | |
| 3,287 | 3,575 | 3,341 | |
Profit | |||
| 3,371 | 3,659 | 3,321 | |
| 2,555 | 2,772 | 2,508 | |
Per share | |||
| ₹51.25 | ₹55.74 | ₹50.74 | |
Revenue detail — as filed | |||
| 27,886 | 25,895 | 22,937 | |
| 3,724 | 3,547 | 3,156 | |
Expense detail — as filed | |||
| 1,772 | 1,728 | 1,516 | |
| 5,049 | 4,484 | 3,838 | |
| 5,049 | 4,484 | 3,838 | |
| 175 | 2,287 | 0.0 | |
| 3,925 | 13,541 | 0.0 | |
| 98.3 | 58.0 | 9.8 | |
| 28.4 | −11.3 | −40.5 | |
| −4.1 | 0.7 | −5.8 | |
Profit build-up — alternate / pre-Ind-AS tags | |||
| 3,371 | 3,659 | 3,321 | |
| 3,371 | 3,659 | 3,321 | |
| 816 | 887 | 813 | |
| 2,555 | 2,772 | 2,508 | |
| 9,860 | 8,860 | 6,759 | |
Per share — as-filed variants | |||
| ₹18.95 | ₹55.74 | ₹50.74 | |
| ₹18.95 | ₹55.74 | ₹50.74 | |
Appropriations & transfers | |||
| 2,224 | 2,524 | 2,267 | |
| 17,467 | — | — | |
| 0.1 | 0.1 | 0.1 | |
| 0.1 | 0.1 | 0.1 | |
Insurance — revenue account (Policyholders') | |||
| 24,078 | 22,264 | 19,800 | |
| 32,069 | 30,618 | 28,258 | |
| 25,268 | 23,374 | 20,761 | |
| 3,225 | 3,059 | 2,845 | |
| 74.1 | 68.6 | 56.2 | |
| 15,516 | 13,541 | 12,487 | |
| 17,387 | 15,828 | 13,987 | |
| 1,871 | 2,287 | 1,500 | |
| — | 26,333 | 24,090 | |
| — | 33,461 | 29,032 | |
Insurance — Shareholders' account | |||
| 3,469 | 3,717 | 3,331 | |
| 1,236 | 1,184 | 1,005 | |
| 2,224 | 2,524 | 2,267 | |
| 0.1 | 0.0 | 0.1 | |
| 0.0 | 0.1 | 0.1 | |
Insurance — result & transfers | |||
| −1,584 | −1,108 | −869 | |
| 2,224 | 2,524 | 2,267 | |
| 9.4 | 9.7 | 59.4 | |
Insurance — IRDAI ratios (as filed, not percentages) | |||
| 2.67× | 2.67× | 2.69× | |
| ₹0.03 | ₹0.03 | ₹0.03 | |
| ₹1.07 | ₹1.03 | ₹1.03 | |
| ₹0.73 | ₹0.71 | ₹0.71 | |
| ₹0.81 | ₹0.76 | ₹0.74 | |
| ₹0.36 | ₹0.32 | ₹0.31 | |
Direct-method operating receipts — filed in the P&L block | |||
| — | 3,291 | 2,966 | |
Regulatory disclosures — filed alongside, not part of the P&L | |||
| ₹0.00 | ₹1.00 | ₹0.00 | |
| ₹0.00 | ₹1.00 | ₹0.00 | |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|
| Other Income | -19.5 | 84.0 | 84.2 | |
| Expenses | ||||
| EBITDA | 3,340.8 | 3,574.9 | 3,286.9 | |
| EBIT | 3,340.8 | 3,574.9 | 3,286.9 | |
| Profit | ||||
| Pretax Income | 3,321.3 | 3,658.9 | 3,371.1 | |
| Net Income | 2,508.3 | 2,771.9 | 2,554.9 | |
| Per Share | ||||
| Basic EPS | 50.74 | 55.74 | 51.25 | |
| Revenue Detail — as filed | ||||
| + Operating Income | 22,936.6 | 25,894.9 | 27,886.3 | |
| + Income from Investments (net) | 3,155.9 | 3,547.4 | 3,724.4 | |
| Expense Detail — as filed | ||||
| + Employee Remuneration & Welfare | 1,515.7 | 1,728.3 | 1,771.9 | |
| + Commission (net) | 3,838.0 | 4,484.2 | 5,049.5 | |
| + Commission & Brokerage (net) | 3,838.0 | 4,484.2 | 5,049.5 | |
| + Provision — Diminution in Investments | 0.0 | 2,287.3 | 175.1 | |
| + Provision — Doubtful Debts & Write-offs | 0.0 | 13,541.2 | 3,924.7 | |
| + Non-operating Expense | 9.8 | 58.0 | 98.3 | |
| + Non-operating Provision — Diminution in Investments | -40.5 | -11.3 | 28.4 | |
| + Non-operating Provision — Doubtful Debts | -5.8 | 0.7 | -4.1 | |
| Profit Build-up — Alternate / Pre-Ind-AS Tags | ||||
| Profit before Extraordinary Items | 3,321.3 | 3,658.9 | 3,371.1 | |
| Profit / (Loss) before Tax — alt tag | 3,321.3 | 3,658.9 | 3,371.1 | |
| + Provision for Tax | 813.0 | 887.0 | 816.2 | |
| Profit / (Loss) after Tax | 2,508.3 | 2,771.9 | 2,554.9 | |
| Profit Carried to Balance Sheet | 6,759.1 | 8,860.2 | 9,860.5 | |
| Per Share — as-filed variants | ||||
| Basic & Diluted EPS before Extraordinary (not annualised) | 50.74 | 55.74 | 18.95 | |
| Basic & Diluted EPS after Extraordinary (not annualised) | 50.74 | 55.74 | 18.95 | |
| Appropriations & Transfers | ||||
| + Transfer to Profit & Loss Account | 2,266.9 | 2,523.7 | 2,224.2 | |
| Reserves & Surplus excl. Revaluation Reserve | — | — | 17,466.7 | |
| + Interim Dividend | 0.1 | 0.1 | 0.1 | |
| + Final Dividend | 0.1 | 0.1 | 0.1 | |
| Insurance — Revenue Account (Policyholders') | ||||
| Premium Earned | 19,800.2 | 22,263.6 | 24,077.7 | |
| + Gross Premiums Written | 28,257.7 | 30,618.1 | 32,069.0 | |
| + Net Premium Written | 20,761.1 | 23,374.5 | 25,268.3 | |
| + Operating Expenses — Insurance Business | 2,844.8 | 3,058.6 | 3,225.3 | |
| + Non-operating Expenses — Non-insurance | 56.2 | 68.6 | 74.1 | |
| + Claims Paid | 12,486.9 | 13,541.2 | 15,516.2 | |
| + Incurred Claims | 13,986.8 | 15,828.5 | 17,387.4 | |
| + Change in Outstanding Claims | 1,500.0 | 2,287.3 | 1,871.1 | |
| + Payments — Premiums, Claims, Annuities & Benefits | 24,090.0 | 26,333.2 | — | |
| + Receipts — Premiums, Claims, Annuities & Benefits | 29,032.0 | 33,461.1 | — | |
| Insurance — Shareholders' Account | ||||
| + Income — Shareholders' Account | 3,331.1 | 3,717.0 | 3,469.3 | |
| + Shareholders' Investment Income | 1,004.8 | 1,183.5 | 1,235.7 | |
| + Transfer from Policyholders' Fund | 2,266.9 | 2,523.7 | 2,224.2 | |
| With Unrealised Gains | 0.1 | 0.0 | 0.1 | |
| Without Unrealised Gains | 0.1 | 0.1 | 0.0 | |
| Insurance — Result & Transfers | ||||
| Underwriting Profit / (Loss) | -869.5 | -1,107.6 | -1,584.4 | |
| Operating Profit / (Loss) | 2,266.9 | 2,523.7 | 2,224.2 | |
| + Other Income — Shareholders' Account | 59.4 | 9.7 | 9.4 | |
| Insurance — IRDAI Ratios (as filed, not percentages) | ||||
| Solvency Ratio (x, one scale) | 2.69 | 2.67 | 2.67 | |
| Solvency Ratio (as filed) | 0.03 | 0.03 | 0.03 | |
| Combined Ratio | 1.03 | 1.03 | 1.07 | |
| Incurred Claim Ratio | 0.71 | 0.71 | 0.73 | |
| Net Retention Ratio | 0.74 | 0.76 | 0.81 | |
| Expenses of Management Ratio | 0.31 | 0.32 | 0.36 | |
| Direct-method Operating Receipts — filed in the P&L block | ||||
| + Other Operating Cash Payments | 2,965.9 | 3,290.6 | — | |
| Regulatory Disclosures — filed alongside, not part of the P&L | ||||
| Investor Complaints — During the Period | 0.00 | 1.00 | 0.00 | |
| Investor Complaints — Received | 0.00 | 1.00 | 0.00 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | ||||
| Operating Expenses | 20,669.7 | 23,371.2 | 25,662.1 | |
| Other Operating Expenses | 1,329.2 | 1,330.3 | 1,453.4 | |